Austrian Pharma Services FlexCo (Regulatory Intelligence Dashboard) — A multilingual regulatory-event archive of 2.5M+ captured events from 120+ authorities (FDA, EMA, MHRA, BfArM, Swissmedic, Health Canada, PMDA, NMPA, MFDS, TGA, ANVISA and others) across seven industry modules, refreshed daily at 800+ new entries. The commercially interesting layers are derived: automated severity categorisation, plain-language summaries and impact assessments per event, inspection intelligence linking FDA facility inspections, 21 CFR citations and warning letters to facilities and freedom-of-information do…
Austrian Pharma Services FlexCo (Regulatory Intelligence Dashboard) — A multilingual regulatory-event archive of 2.5M+ captured events from 120+ authorities (FDA, EMA, MHRA, BfArM, Swissmedic, Health Canada, PMDA, NMPA, MFDS, TGA, ANVISA and others) across seven industry modules, refreshed daily at 800+ new entries. The commercially interesting layers are derived: automated severity categorisation, plain-language summaries and impact assessments per event, inspection intelligence linking FDA facility inspections, 21 CFR citations and warning letters to facilities and freedom-of-information do…
Austrianpharmaservices offers (Alternative, Reference, Sentiment) — 2.5M+ captured regulatory events with 800+ new entries per day (on the order of 290,000 events a year at the current rate), spanning 120+ authorities across seven industry modules, plus the full text of the underlying agency documents in 30+ original languages each paired with a stored translation, an automated summary and an impact assessment..
Parallel multilingual corpus for regulatory and clinical prose — 30+ original languages with originals retained beside their translations, which is an aligned translation-pair set rather than a monolingual dump; training of severity-triage and impact-assessment models over the labelled event stream; facility-to-inspection entity linking and GMP certificate lifecycle models; cross-agency divergence models built from the ICH matrix; supplier and manufacturer compliance risk scoring; and alternative-data features for listed pharmaceutical and medical-device issuers derived from approval, refusal, recall and supply-notice events.
Coverage spans US, Europe; Biotechnology, Pharmaceuticals, Research & Consulting Services; alternative, reference, sentiment; equities.
Not yet on file: Summary & mission · Use cases & buyers · FAQ